The latest issue of Advances in Pulmonary Hypertension is now online. The issue addresses emerging treatment pathways, technological innovations and equitable drug development. Advances is the Pulmonary Hypertension Association’s quarterly peer-reviewed clinical journal.
Volume 23, Issue 2, includes articles on:
- Multiomics Integration for Identifying Treatment Targets, Drug Development and Diagnostic Designs.
- Incorporation of Risk Stratification.
- CardioMEMS and Remote Hemodynamic Monitoring.
- Tyrosine Kinase Inhibitors for Treatment of PAH.
- Racial and Ethnic Equity in Clinical Trials.
- Pulmonary Artery Intimal Sarcoma and the Role of Vasodilator Therapy.
“This issue of Advances in Pulmonary Hypertension is focused on [the] future,” state guest editors Thomas Cascino, Mardi Gomberg-Maitland and Soni Pullamsetti. “This edition brings together thought leaders who elaborate on opportunities from drug development to implementation of clinical care.”
Read Advances in Pulmonary Hypertension for free online. Learn when future issues are available.
